Tuesday, March 31, 2015

Best Low Price Companies To Invest In 2014

While natural gas struggles to get up and running on the export side because of regulatory and infrastructure constraints, natural gas liquids (NGLs) are experiencing massive export growth. Enterprise Products Partners (NYSE: EPD  ) is right in the middle of that opportunity.

You can't export that stuff...
Up until recently, there wasn't any reason to export natural gas because we used everything we had and then some. But things are different now, and gas drillers are looking to get more U.S. oil and gas on the water. The big reason is that U.S. natural gas is trading at disproportionately low prices when compared to key demand centers around the world.

While export terminals are slowly being approved, they take years to develop. And major U.S. gas users like chemical giant Dow Chemical (NYSE: DOW  ) are openly pushing back. Dow Chemical's CEO Andrew Liveris commented after a late 2013 liquefied natural gas export-terminal approval:

The most recent data makes clear that sending large volumes of American natural gas abroad will raise consumer energy prices, discourage manufacturing investment, and impede economic growth and job creation.

Best Chemical Companies To Watch For 2015: Synageva BioPharma Corp (GEVA)

Synageva BioPharma Corp., incorporated in 1993, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products. It has several protein therapeutics in development, including two enzyme replacement therapies for lysosomal storage disorders and two programs for life-threatening genetic conditions. Its lead program, SBC-102, recombinant human lysosomal acid lipase (LAL), is its advanced pipeline program in clinical development for LAL Deficiency. This enzyme is responsible for the metabolism of cholesteryl esters and triglycerides that are delivered to lysosomes by a variety of routes, including low-density lipoprotein receptor mediated endocytosis. On November 2, 2012, Trimeris, Inc. merged with Synageva BioPharma Corp.

SBC-102 is produced by recombinant deoxyribonucleic acid (DNA) technology in egg white using its protein manufacturing platform. The Company has initiated natural history studies in approximately 20 countries. In addition to SBC-102, it is progressing protein therapeutic programs for other rare diseases, which are at different stages of preclinical development. These include two enzyme replacement therapies for other lysosomal storage disorders and two programs for other rare life-threatening conditions. As of December 31, 2011, its product candidate pipeline included SBC-102, SBC-103, SBC-104, SBC-105 and SBC-106.

SBC-104 is an extracellular protein that targets a severe, rare genetic condition. SBC-105 is an enzyme replacement therapy being developed to treat a severe, rare metabolic disorder. SBC-106 is a protein therapy that targets a severe and rare genetic condition.

Advisors' Opinion:
  • [By Ben Levisohn]

    Somaiya and team named Gilead and�Neurocrine Biosciences (NBIX) their top picks, hile putting Buy ratings on Celgene, Biogen Idec, Alexion (ALXN), Incyte (INCY), Pharmacyclics (PCYC) and Synageva (GEVA). BioMarin (BMRN), Infinity Pharmaceuticals (INFI) and Amgen (AMGN) earned Neutral ratings.

Best Low Price Companies To Invest In 2014: Citadel Capital SAE (CCAP)

Citadel Capital SAE is an Egypt-based company engaged in the private equity investment activities. The Company manages an investment portfolio that consist of 19 Opportunity-Specific Funds (OSFs), which controls entities platform distributed across 12 countries in the Middle Eastern and North African markets, and span 14 industrial sector such as energy, cement manufacturing, solid waste management, real estate, mining, agricultural, glass manufacturing, transportation and metallurgy. Its OSFs entities include Asec Holding, Ascom Geology and Mining SAE, Nile Logistics, Rift Valley Railways, Gozour, Wafra, Nopc / Rally Energy Group, Nile Valley Petroleum Ltd, Egyptian Refining Company, Taqua Arabia, GlassWorks and Finance Unlimited, among others. On December 9, 2012, the Company announced that it has sold 100% of its interest in National Petroleum Company Egypt Limited (NPC Egypt), a wholly owned portfolio company, to Sea Dragon Energy Inc. Advisors' Opinion:
  • [By Joshi Madhavi]

    Charlemagne Capital Limited (CCAP) is an established asset management group in the UK with an exclusively emerging markets focus and bottom-up stock picking process. The business is cyclical with fortunes linked to emerging market performance. The company�� strategy is to grow each category within its broad fund range: mutual funds, hedge funds, specialist funds and institutional products.

  • [By Julia Leite]

    Declines provided an opportunity for ��rofit taking��for ��hort term players who bought in the last week or so,��Julian Mayo, who helps manage $2.5 billion in emerging-market assets as the co-chief investment officer at Charlemagne Capital Ltd. (CCAP) in London, said by e-mail. ��fter a 5 to 10 percent gain in some emerging markets in such a short time, some correction is always likely.��

Best Low Price Companies To Invest In 2014: Select Comfort Corporation(SCSS)

Select Comfort Corporation develops, manufactures, markets, and distributes adjustable-firmness beds and other sleep-related accessory products in the United States, Alaska, Hawaii, Canada, and Australia. It offers its mattresses under the Sleep Number brand name. The company also provides a line of accessory bedding products, including specialty pillows, mattress pads, comforters, sheets, and leg options. Select Comfort Corporation distributes its products through retail, direct marketing, and e-commerce channels. As of January 2, 2010, it had 403 company-owned stores and 146 retail partner doors. The company was founded in 1987 and is headquartered in Minneapolis, Minnesota.

Advisors' Opinion:
  • [By Peter Graham]

    The Q2 2014 earnings report for mattress stock Select Comfort Corp (NASDAQ: SCSS), a potential peer or competitor of other mattress players like Mattress Firm Holding Corp (NASDAQ: MFRM) and Tempur Sealy International Inc (NYSE: TPX), is due out on Wednesday after the market closes. Aside from the Select Comfort Corp earnings report, it should be said that the estimated release date for the Mattress Firm Holding Corp Q2 2014 earnings report is the the week of September 4th while the estimated date for the Tempur Sealy International Inc Q2 2014 earnings report is the week of July 21st. And while the last earnings report from Select Comfort Corp did not cause shares to move much, shares plunged 19% in January as�preliminary fourth quarter results reignited concerns over growth going forward. This came after a 25% plunge after an October earnings report�badly missed expectations.

  • [By Monica Gerson]

    Select Comfort (NASDAQ: SCSS) is estimated to post its Q1 earnings at $0.32 per share on revenue of $274.27 million.

    E. I. du Pont de Nemours and Company (NYSE: DD) is projected to report its Q1 earnings at $1.58 per share on revenue of $10.45 billion.

Best Low Price Companies To Invest In 2014: Syneron Medical Ltd. (ELOS)

Syneron Medical Ltd., together with its subsidiaries, engages in the research, manufacture, development, marketing, and sale of aesthetic medical products worldwide. The company develops products based on its proprietary Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy and optical energy to provide aesthetic medical treatments. Its products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin�s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, laser-assisted lipolysis, and topical skin brightening products. It also develops, manufactures, and markets non-invasive technologies for fat cell destruction and body sculpting; and Viador system, a handheld device with a radiofrequency-needle array for use in transdermal delivery of biologic drug-products via a system-specific skin patch. The company sells its products to dermatologists, plastic and cosmetic surgeons, other qualified practitioners, and aestheticians and medical spas through direct sales force and distributors; and to home-use consumers directly, as well as through retailers and a chain of distributors. Syneron Medical Ltd. was founded in 2000 and is headquartered in Yokneam Illit, Israel.

Advisors' Opinion:
  • [By Eric Volkman]

    Syneron Medical (NASDAQ: ELOS  ) has put a familiar person on its CEO throne. The company named Shimon Eckhouse as its new chief executive, effective immediately. He succeeds Louis Scafuri, who will "remain available" to the firm through the current quarter to aid in the transition.

  • [By John Udovich]

    Large cap serial acquirer�Valeant Pharmaceuticals International Inc (NYSE: VRX) is teaming up with activist investor�Bill Ackman to pursue large cap Botox maker Allergan, Inc (NYSE: AGN), but stocks like Cutera, Inc (NASDAQ: CUTR), Cynosure, Inc (NASDAQ: CYNO), PhotoMedex Inc (NASDAQ: PHMD) and Syneron Medical Ltd (NASDAQ: ELOS)�actually offer investors more exposure to the growing anti aging and aesthetics market (Note: See my recent article: These Small Caps Seek to Treat Your Crow�� Feet and Double Chin (RVNC & KYTH)). To begin with, Valeant Pharmaceuticals International has a wide focus on neurology, dermatology and infectious diseases�but acquiring the maker of Botox won�� be its first foray into the aesthetic market�because earlier this year, the company completed its acquisition of Solta Medical Inc (NASDAQ: SLTM) -�a designer, developer, manufacturer and marketer of�energy-based medical device systems for aesthetic applications.�And while�Allergan, Inc may be most well known for Botox, its actually a pretty big�company focused on a diverse range of areas, including ophthalmic pharmaceuticals, dermatology, neuroscience, urology and cosmetics���meaning the following stocks offer investors better exposure to the aesthetics market:

Best Low Price Companies To Invest In 2014: Qlik Technologies Inc.(QLIK)

Qlik Technologies Inc. engages in the development, commercialization, and implementation of software products and related services for user-driven business intelligence that enables customers to make business decisions primarily in the Americas, Europe, the Asia-Pacific region, and Africa. It provides QlikView Business Discovery platform, which helps people create and share insights and analysis in groups and across organizations. Business users can explore data, ask and answer their own stream of questions, and follow their own path to insight on their own and in teams and groups. The company also offers maintenance and professional services. It sells its products to a range of industry verticals, including consumer packaged goods, financial services, pharmaceuticals, retail, manufacturing, technology, and healthcare through its direct sales force, as well as through an indirect channel partners comprising distribution partners, value-added resellers, system integrators, and original equipment manufacturers to license and support its software platform. The company was founded in 1993 and is headquartered in Radnor, Pennsylvania.

Advisors' Opinion:
  • [By Eric Volkman]

    Qlik Technologies (NASDAQ: QLIK  ) will have a new CFO once July rolls around. The company said that Tim MacCarrick is to take up the post on July 1. He replaces Bill Sorenson, who announced his departure from the firm in February. The two men will temporarily work together to "ensure a smooth transition," according to a company press release announcing the news.

  • [By Lauren Pollock]

    Qlik Technologies Inc.'s(QLIK) third-quarter earnings soared due to a tax benefit, but higher costs more than offset revenue growth. Shares dropped as revenue missed expectations and the company’s outlook for the current quarter was short of analysts’ estimates.

  • [By Garrett Cook]

    Shares of Qlik Technologies (NASDAQ: QLIK) got a boost, shooting up 12.48 percent to $26.31 after the company reported better-than-expected quarterly results.

  • [By Luke Jacobi]

    Shares of Qlik Technologies (NASDAQ: QLIK) got a boost, shooting up 14.7 percent to $26.83 after the company reported better-than-expected quarterly results.

Best Low Price Companies To Invest In 2014: NuStar GP Holdings LLC (NSH)

NuStar GP Holdings, LLC (NuStar GP Holdings), incorporated on June 06, 2000, conducts operations through its indirect ownership interests in NuStar Energy L.P. (NuStar Energy). NuStar Energy is engaged in the terminalling and storage of petroleum products, the transportation of petroleum products and anhydrous ammonia, and petroleum refining and marketing. The Company operates in three segments: NuStar Energy�� Storage Segment, NuStar Energy�� Pipeline Segment and NuStar Energy�� Asphalt and Fuels Marketing Segment. On January 1, 2013, NuStar Energy sold the San Antonio Refinery and related assets, which included inventory, a terminal in Elmendorf, Texas and a pipeline connecting the terminal and refinery. On December 13, 2012, NuStar Energy completed its acquisition of the TexStar Crude Oil Assets (as defined below), including 100% of the partnership interest in TexStar Crude Oil Pipeline, LP, from TexStar Midstream Services, LP and certain of its affiliates.

NuStar Energy has terminal and storage facilities in the United States, Canada, Mexico, the Netherlands, including St. Eustatius in the Caribbean, the United Kingdom and Turkey. NuStar Energy L.P.'s asphalt refineries, refined product terminals, petroleum and specialty liquids storage and terminaling operations, and crude oil storage tank facilities are predominantly located on waterways that are easily accessible by barge or vessel. On September 28, 2012, NuStar Energy sold a 50% ownership interest (the Asphalt Sale) in NuStar Asphalt LLC (Asphalt JV), previously a wholly owned subsidiary of NuStar Energy, to an affiliate of Lindsay Goldberg LLC (Lindsay Goldberg), a private investment firm.

Advisors' Opinion:
  • [By Robert Rapier]

    But it is important to note that ETE also has interests in Sunoco Logistics Partners (NYSE: SXL) and Regency Energy Partners (NYSE: RGP).

    Finally, consider NuStar Energy (NYSE: NS) and its general partner NuStar GP Holdings (NYSE: NSH). Like ETE, NSH went public in 2006 and has also significantly outperformed its limited partner since:


    The vast majority of partnerships don’t have a publicly-traded GP. But in each of these three cases in which the GP is publicly traded, the GP tends to outperform the LP units on long-term gains, an advantage somewhat offset by the typically higher LP yield.

  • [By Robert Rapier]

    NuStar Energy does have a publicly traded general partner in�NuStar GP Holdings�(NYSE: NSH) which went public in 2006. The GP pays a lower dividend at 5.8 percent, but has significantly outperformed the limited partner since it went public:

No comments:

Post a Comment